Ronald van Marion
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, Esophageal Cancer Research and Treatment, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group(2010)381 cited
- → TMPRSS2:ERG Fusion by Translocation or Interstitial Deletion Is Highly Relevant in Androgen-Dependent Prostate Cancer, But Is Bypassed in Late-Stage Androgen Receptor–Negative Prostate Cancer(2006)239 cited
- → IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide(2009)187 cited
- → Verification and Unmasking of Widely Used Human Esophageal Adenocarcinoma Cell Lines(2010)128 cited
- → IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study(2016)102 cited
- → Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients(2020)101 cited
- → Segregation of non-p.R132H mutations inIDH1in distinct molecular subtypes of glioma(2010)98 cited
- → Truncated ETV1, Fused to Novel Tissue-Specific Genes, and Full-Length ETV1 in Prostate Cancer(2008)97 cited
- → High‐resolution array comparative genomic hybridization of chromosome arm 8q: Evaluation of genetic progression markers for prostate cancer(2005)92 cited
- → Diagnostic Detection of Allelic Losses and Imbalances by Next-Generation Sequencing(2016)74 cited